WTA
AXSM icon

Washington Trust Advisors’s Axsome Therapeutics AXSM Stock Holding History

Washington Trust Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.3K Hold
250
– – ﹤0.01% 370
2025
Q4 		$45.7K Hold
250
– – ﹤0.01% 362
2025
Q3 		$30.4K Hold
250
– – ﹤0.01% 402
2025
Q2 		$26.1K Hold
250
– – ﹤0.01% 376
2025
Q1 		$29.2K Sell
250
-80
-24% -$9.11K ﹤0.01% 366
2024
Q4 		$27.9K Hold
330
– – ﹤0.01% 379
2024
Q3 		$29.7K Hold
330
– – ﹤0.01% 384
2024
Q2 		$26.6K Hold
330
– – ﹤0.01% 379
2024
Q1 		$26.3K Hold
330
– – ﹤0.01% 376
2023
Q4 		$26.3K Buy
+330
New +$22.1K ﹤0.01% 369

Other funds holding AXSM

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return